Emerald Mutual Fund Advisers Trust’s Tandem Diabetes Care TNDM Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-240,460	Closed	-$11.5M	–	242
2022 Q3	$11.5M	Sell	240,460 -90,725	-27%	-$4.97M	0.73%	58
2022 Q2	$19.6M	Buy	+331,185	New	+$27.2M	1.14%	26
2020 Q2	–	Sell	-221,736	Closed	-$14.3M	–	332
2020 Q1	$14.3M	Sell	221,736 -121,122	-35%	-$8.49M	0.89%	36
2019 Q4	$20.4M	Sell	342,858 -199,472	-37%	-$12.3M	0.83%	40
2019 Q3	$32M	Buy	542,330 +323	+0.1%	+$20.6K	1.42%	16
2019 Q2	$35M	Sell	542,007 -10,000	-2%	-$645K	1.39%	15
2019 Q1	$35.1M	Sell	552,007 -157,784	-22%	-$8.29M	1.41%	9
2018 Q4	$27M	Buy	709,791 +105,725	+18%	+$3.73M	1.26%	12
2018 Q3	$25.9M	Sell	604,066 -101,492	-14%	-$3.54M	0.87%	27
2018 Q2	$15.5M	Buy	+705,558	New	+$8.68M	0.56%	62
2014 Q2	–	Sell	-5,234	Closed	-$1.16M	–	238
2014 Q1	$1.16M	Sell	5,234 -2,258	-30%	-$576K	0.11%	146
2013 Q4	$1.89M	Buy	+7,492	New	+$1.71M	0.11%	143

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TNDM Position: Q4 2022 in Review

Emerald Mutual Fund Advisers Trust sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 240,460 shares — an estimated $11.5M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TNDM in Q4 2013 and held it in 12 quarters. The position peaked at $35.1M in Q1 2019. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

Emerald Mutual Fund Advisers Trust reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 240,460 Tandem Diabetes Care shares in Q4 2022, an estimated $11.5M.
Emerald Mutual Fund Advisers Trust first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 12 quarters.
Emerald Mutual Fund Advisers Trust's Tandem Diabetes Care position peaked at $35.1M in Q1 2019.
295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2022, filed 3 Feb 2023.